Clinical and economic burden of benign and malignant skin lesions in renal transplant recipients

Clinical and economic burden of benign and malignant skin lesions in renal transplant recipients

Background Studies evaluating the economic burden of dermatological care in the transplant setting are currently not available in Australia. Aims To evaluate the clinical and economic burden of benign and malignant skin lesions in renal transplant recipients in Central Queensland. Methods A bottom‐u...

Full description

Saved in:
Bibliographic Details
Published in:Internal medicine journal Vol. 53; no. 11; pp. 2042 - 2049
Main Authors: Thet, Zaw, Lam, Alfred K., Pham, Tony, Ng, Shu‐Kay, Steel, Jason C., Sawhney, Sirena, Arellano, Carolina T., Aung, Soe Yu, Han, Thin, Ranganathan, Dwarakanathan, John, George, Pepito, Christina, Rautenberg, Tamlyn, Khoo, Tien K.
Format: Journal Article
Language:English
Published: Melbourne John Wiley & Sons Australia, Ltd 01-11-2023
Wiley Subscription Services, Inc
Subjects:
Benign
health economics
health expenditure
Kidney transplantation
Kidney transplants
Medicare
Melanoma
nonmelanoma skin carcinoma
Patients
renal transplant
Skin cancer
Skin carcinoma
Skin diseases
Skin lesions
Queensland Australia
Australia
nonmelanoma skin carcinoma
skin cancer
health expenditure
renal transplant
health economics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Studies evaluating the economic burden of dermatological care in the transplant setting are currently not available in Australia. Aims To evaluate the clinical and economic burden of benign and malignant skin lesions in renal transplant recipients in Central Queensland. Methods A bottom‐up approach was used to determine the clinical burden and direct costs from patient‐level Medicare data obtained from Service Australia for skin lesions. Results Seventy‐six percent of the renal transplant population in Central Queensland participated in this study. The median age was 57.0 years (standard deviation ± 13.6) and the majority (61.8%) of participants were men. The mean duration after transplant surgery was 99.9 months (interquartile range, 73.2–126.6 months). During a 2‐year follow‐up, 22 (40%) patients were diagnosed with benign skin lesions, 21 (38%) with nonmelanoma skin carcinoma (NMSC) and one (2%) with melanoma. There was a total of 231 visits to clinicians for diagnostic and therapeutic skin procedures and the direct costs to Medicare was $48 806 Australian Dollars (AUD) or $30 427 US Dollars (USD). Approximately 86% of the total direct costs was spent for nonNMSC and mean direct costs for NMSC was $763 AUD (or $476 USD). Conclusion This Medicare data‐based study provides further insight into the burgeoning clinical and economic burden of the care for benign and malignant skin lesions in the renal transplantation setting in Australia.
Bibliography:Conflict of interest: None.
Funding: Research Ready Grant Program (a collaborative project involving Central Queensland Hospital Health Service [CQHHS], Central Queensland University [CQU] and The University of Queensland [UQ]).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1444-0903
1445-5994
DOI:10.1111/imj.16024